Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Upendra P. Hegde"'
Autor:
Sarah Kamsiah Zemlok, BA, Sulaikha Buuh, BA, Regina Brown, MD, MPH, Michael Murphy, MD, Upendra P. Hegde, MD, Janelle R. Mallett, MD, MBA
Publikováno v:
JAAD Case Reports, Vol 38, Iss , Pp 23-26 (2023)
Externí odkaz:
https://doaj.org/article/220daec0636241a8818e7ef4611a435b
Autor:
Aaron N. Holmes, Helen Swede, Wendy M. Feer, Donna Comins Pike, Xiaoyan Wang, Upendra P. Hegde
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Immune-related adverse events (irAEs) are a major toxicity of immune checkpoint inhibitors. Studies have reported that pre-existing autoimmunity increases the risk of irAEs, but it remains unknown which clinical factors are linked
Externí odkaz:
https://doaj.org/article/af3a63eacc4044b9976770070309804f
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 6, Iss , Pp 100154- (2022)
High-risk human papillomavirus (HR HPV) is associated with oropharyngeal squamous cell carcinoma (OPSCC), which is rising. Although the association and mechanism of viral carcinogenesis are well established, the exact risk and time of cancer developm
Externí odkaz:
https://doaj.org/article/ba64d76c8cf34d27af124ab04987f746
Autor:
Nerea Lopetegui Lia, Abigael Luke, Syed Daniyal Asad, Shashank Sama, Leo J. Wolansky, Upendra P. Hegde
Publikováno v:
Clinical Case Reports, Vol 8, Iss 11, Pp 2148-2151 (2020)
Abstract It is important to obtain coagulation tests to assess bleeding risk in trauma patients undergoing emergency surgery when a bleeding disorder may be obscured. Identifying specific clotting factor defects is critical in successful patient mana
Externí odkaz:
https://doaj.org/article/2c95a3b40cdb4e3b9497d07dc9297f87
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:207-211
Introduction Immune agents including anti-programmed death receptor-1 and anti-cytotoxic T-lymphocyte antigen-4 have been associated with numerous immune-related complications. Pembrolizumab, a programmed death-1 inhibitor, has been associated with a
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Background Immune-related adverse events (irAEs) are a major toxicity of immune checkpoint inhibitors. Studies have reported that pre-existing autoimmunity increases the risk of irAEs, but it remains unknown which clinical factors are linked to auto-
Publikováno v:
Journal of Clinical Oncology. 40:e21514-e21514
e21514 Background: Tumor infiltrating lymphocytes (TILs) in the tumor microenvironment generate anti-tumor immunity and are associated with response to immune checkpoint inhibitor (ICI) therapy of melanoma. However, likelihood of response to ICI ther
Autor:
Amanda K. Dupuy, Bo-Young Hong, Linda D. Strausbaugh, Upendra P. Hegde, Andrew L. Salner, A. Cardenas, Anilei Hoare, Linda Choquette, Anna Dongari-Bagtzoglou, Douglas E. Peterson, Patricia I. Diaz, Peter K. Schauer
Publikováno v:
J Dent Res
A broad range of fungi has been detected in molecular surveys of the oral mycobiome. However, knowledge is still lacking on interindividual variability of these communities and the ecologic and clinical significance of oral fungal commensals. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f3e686cd4e4eb9d489faaffa1962b3
https://europepmc.org/articles/PMC7243416/
https://europepmc.org/articles/PMC7243416/
Autor:
Upendra P. Hegde, Bijay Mukherji
Publikováno v:
Cancer Immunology, Immunotherapy
Adoptive cell therapies with chimeric antigen receptor (CAR) engineered T cells (CAR-T) and immune checkpoint inhibition (ICI)-based cancer immunotherapies have lately shown remarkable success in certain tumor types. CAR-T cell-based therapies target
Autor:
Angela Thompson, Anna Dongari-Bagtzoglou, Amanda K. Dupuy, Patricia I. Diaz, Linda D. Strausbaugh, Joseph A. Burleson, Linda Choquette, Upendra P. Hegde, Bo-Young Hong, Peter K. Schauer, Douglas E. Peterson, Andrew L. Salner
Publikováno v:
Journal of Fungi
Journal of Fungi, Vol 5, Iss 2, p 49 (2019)
Volume 5
Issue 2
BASE-Bielefeld Academic Search Engine
Journal of Fungi, Vol 5, Iss 2, p 49 (2019)
Volume 5
Issue 2
BASE-Bielefeld Academic Search Engine
Oral candidiasis is a common side effect of cancer chemotherapy. To better understand predisposing factors, we followed forty-five subjects who received 5-fluorouracil- or doxorubicin-based treatment, during one chemotherapy cycle. Subjects were eval